Andrew Sharabi Lab
Dr. Sharabi’s research is focused on elucidating fundamental interactions between radiation and the immune system. He has published extensively on how radiation can augment immunotherapy and is currently the principal investigator on a novel randomized trial evaluating the benefit of SBRT in patients undergoing immunotherapy. He also serves as a Co-Investigator on a U-01 Moonshot Grant focused on immunotherapy in Head & Neck cancer.